壺化股份(003002.SZ):電子雷管、工業電雷管、導爆管雷管、膠狀乳化炸藥已廣泛用於國防工程
格隆匯9月5日丨壺化股份(003002.SZ)在投資者關係活動上表示,公司全資子公司壺化進出口,專業從事民爆產品及相關原材料的進出口業務,出口蒙古、緬甸、澳大利亞、津巴布韋等20餘個國家和地區。軍工領域,擁有“軍工四證”,開展軍用電雷管、軍用電子雷管、TNT藥塊等軍用產品的科研、生產和銷售;公司電子雷管、工業電雷管、導爆管雷管、膠狀乳化炸藥已廣泛用於國防工程;參股了成都飛亞航空、航天科工火箭、重慶新承航鋭等國內優秀軍工企業,軍工產業佈局不斷深化。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.